Carboxylesterase 1g (Ces1g) is a member of a broad family of carboxylesterases that play a critical role in the metabolism of various endogenous and exogenous substances. Ces1g, specifically, is an enzyme predominantly expressed in the liver, where it is involved in the hydrolysis of ester- and amide-containing compounds, participating in the physiological processing of dietary fats and cholesterol, as well as the metabolic clearance of certain pharmaceuticals and xenobiotics. This enzyme's activity reflects the body's capacity to breakdown various lipid-soluble substances, facilitating their subsequent elimination or transformation into more hydrophilic metabolites. The expression of Ces1g is not static and can be upregulated by a variety of chemical compounds, which often trigger complex intracellular signaling pathways leading to transcriptional activation of the CES1G gene. Understanding the modulators of Ces1g expression is crucial for comprehending how the body adapts to various environmental exposures and maintains metabolic homeostasis.
Several chemical activators have been identified that can induce the expression of Ces1g through different molecular mechanisms. Compounds such as fenofibrate, clofibrate, and gemfibrozil, known as fibrates, are recognized for their ability to stimulate PPARα, a nuclear receptor that upon activation can enhance the transcription of genes involved in fatty acid oxidation and lipid metabolism, including Ces1g. Pioglitazone and rosiglitazone, categorized as thiazolidinediones, activate PPARγ, which can also lead to increased Ces1g expression, illustrating the interconnectedness of lipid metabolism pathways. Other activators, like rifampicin and phenobarbital, are potent inducers of enzymes through their action on nuclear receptors such as PXR and CAR, which regulate the expression of genes involved in detoxification processes. Additionally, compounds like omeprazole and carbamazepine engage these receptors, indicating a broader scope of substances that can modulate Ces1g levels. Antioxidants like tert-butylhydroquinone (tBHQ) can induce Ces1g through activation of the Nrf2 pathway, a critical regulator of cellular defense mechanisms against oxidative stress. These activators exemplify the diverse chemical interactions that can influence Ces1g expression, reflecting the enzyme's central role in the metabolic adaptability of the organism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate is known to activate peroxisome proliferator-activated receptor alpha (PPARα), leading to an upsurge in Ces1g transcription as part of the broader lipid catabolism process. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Clofibrate is a PPARα agonist that can stimulate the transcription of Ces1g by promoting the catabolism of fatty acids, a function pivotal in maintaining lipid homeostasis. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Gemfibrozil, by acting as a PPARα agonist, can elevate the expression levels of Ces1g, potentially enhancing the hydrolysis of esters and amides in various lipophilic compounds. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, through PPARγ activation, can initiate the transcriptional cascade that leads to increased Ces1g expression, playing a role in the metabolism of endogenous and exogenous substances. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone activates PPARγ, which in turn can trigger a transcriptional response that elevates Ces1g levels, thus influencing the body's lipid and glucose metabolism pathways. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin can activate the pregnane X receptor (PXR), which may lead to a heightened expression of Ces1g, reflecting its role in enhancing the body's detoxifying processes. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole's ability to activate PXR could result in a cascade of genetic activations, resulting in the upsurge of Ces1g expression, an enzyme central to detoxification pathways. | ||||||
Carbamazepine | 298-46-4 | sc-202518 sc-202518A | 1 g 5 g | $33.00 $71.00 | 5 | |
Carbamazepine's induction of Ces1g is mediated through the activation of CAR and PXR, which are nuclear receptors that stimulate the transcription of genes involved in the metabolism of foreign substances. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can elevate Ces1g expression through a glucocorticoid receptor-mediated transcriptional response, which is integral to the body's adaptive processes to stress and metabolic changes. | ||||||
t-Butylhydroquinone | 1948-33-0 | sc-202825 | 10 g | $67.00 | 4 | |
t-Butylhydroquinone can stimulate the Nrf2 pathway, which can enhance the transcription of detoxification enzymes like Ces1g, playing a crucial role in maintaining cellular redox homeostasis. | ||||||